Generic placeholder image

Current Enzyme Inhibition


ISSN (Print): 1573-4080
ISSN (Online): 1875-6662

Tacrolimus Toxicity Reverses the Inhibitory Effects of Renin Angiotensin System Blockade on PAI-1 Expression in Cardiac Tissue

Author(s): Mehmet Agirbasli, Emine Bas Bozkurtlar, Nurdan Papila-Topal, Hicran Deniz, Betul Ogutmen and Fulya Cakalagaoglu

Volume 9 , Issue 2 , 2013

Page: [83 - 88] Pages: 6

DOI: 10.2174/1573408011309020002

Price: $65


Introduction: PAI-1 is a potent fibrosis promoting glycoprotein in a tissue dependent manner. We previously displayed that tacrolimus (FK506) toxicity increases vacuolar degeneration and arterial hyalinosis in cardiovascular tissue. FK506 toxicity induced transforming growth factor (TGF-β) expression. Renin angiotensin system (RAS) blockade partially reversed histopathological changes associated with FK506 toxicity. In the same model, we investigated the effects of FK506 and RAS blockade on PAI-1 expression.

Materials and Methods: We examined cardiac expression of PAI-1 in a chronic FK506 toxicity model in Wistar rats. Study animals were divided into 4 groups. FK506 group was treated with FK506 intraperitoneally, FK506+Quinapril and FK506+Valsartan groups were treated Quinapril or Valsartan orally in addition to FK506. Control group was treated with saline. Immunohistochemical staining of cardiovascular tissue was semiquantitatively scored for PAI-1 expression.

Results: FK506 significantly induced PAI-1 expression in the cardiovascular tissue compared to the control group (semiquantitative scores were 25±5 versus (vs) 49±21, p =0.01). Adding renin angiotensin system blockade with an angiotensin converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) to FK506 increased FK506 induced PAI-1 expression. Semiquantitative PAI-1 expression scores were 49±21, 87±14 and 95±10 for FK506, FK506+ACEI, and FK506+ARB groups respectively (p<0.01).

Conclusion: FK506 toxicity is associated with up-regulation of PAI-1 expression at the tissue level which is not attenuated after RAS blockade. These observations suggest that FK506 induces an angiotensin II independent increase on PAI-1 expression in cardiac tissue and/or elevated TGF-β and reduced BMP-7 levels with FK506 toxicity may reverse the inhibitory effects of RAS blockade on PAI-1 expression.

Keywords: Tacrolimus, cardiac toxicity, renin-angiotensin system, PAI-1.

Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy